About me

PharmD, Observer - Financière Arbevel.Louis Geslin

Louis joined Financière Arbevel in 2016 as an equity analyst for the Pluvalca Health fund. He launched the Private Equity Healthcare division at Financière Arbevel in 2018 and has been co-managing it since.

Louis is a board member for portfolio companies amongst which Germitec, NG Biotech, and TransCure BioServices.


About Louis Geslin

Louis holds a Doctorate of Pharmacy and is a graduate of ESSEC Business School.


Michel Therin
DVM, PhD, Chairman of the BoardMichel Therin
Denise Hoblingre
CEODenise Hoblingre
Valérie Calenda
PhD, partner at Mérieux Développement Investment FundValérie Calenda
Celia Hart
PhD, General Partner at Supernova Invest FundCelia Hart
Philippe Tourrette
President Tourrette Investissement FundPhilippe Tourrette